Thursday, July 9, 2026

pharma · Alcohol Use Disorder · CMND

Clearmind Medicine

Clearmind Medicine is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker CMND. Primary therapeutic focus areas include Alcohol Use Disorder. NovaPharmaNews links 1 clinical program(s), 0

Vancouver, CA HQ
2021 Founded
7 Employees
Public company Type
CMND · NYSE Ticker
Company details
Status
Public
HQ
Vancouver, CA
Founded
2021
Employees
7
Programs
1
Drugs
1
Patents
5

Quick answer

Clearmind Medicine is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker CMND. Primary therapeutic focus areas include Alcohol Use Disorder. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 5 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO sources. Pipeline phase mix: phase 2 (1).

Company snapshot

Clearmind Medicine (Nasdaq: CMND, FSE: CWY0) develops novel psychedelic medicines to solve widespread, yet under-served, health problems. With a strong medical management team and IP-protection, we can better the lives of millions. With a clear focus on alcohol abuse and binge drinking, Clearmind's first drug candidate addresses very common (and costly) afflictions which to date, have limited solu

  • 1 active pipeline program(s) linked via ClinicalTrials.gov.
  • 5 US patent(s) indexed to this assignee profile.
  • 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Clearmind Medicine. Not investment advice.

Lead pipeline drugs

Active clinical programs

Momentum

Proprietary activity score for Clearmind Medicine.

1 active signal

7 /100 +0 vs 30 days ago

Signal breakdown

  • Clinical trials 1 30d
  • Nova articles 0 30d
  • Patents filed 0 30d
  • FDA actions 0 30d
  • SEC filings 0 30d
  • Conference presentations 0 90d
  • Pipeline advances 0 30d

Recent activity

Latest pipeline, patent, and corporate events for Clearmind Medicine.

  1. Clinical update

    CMND-100 — Phase 2

  2. Patent grant

    Binge behavior regulators

  3. Patent grant

    Binge behavior regulators

  4. Patent grant

    Binge behavior regulators

  5. Patent grant

    Alcoholic beverage substitutes

View all clinical trial activity →

Quick answers

Common questions about this sponsor — for analysts and search.

  • What is Clearmind Medicine?

    Clearmind Medicine is a pharma organization headquartered in Vancouver, CA. It trades on NYSE under ticker CMND. Primary therapeutic focus areas include Alcohol Use Disorder. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 5 patent record(s) to this entity from

  • Is Clearmind Medicine publicly traded?

    Yes. Clearmind Medicine is listed with ticker CMND on NYSE per SEC EDGAR records linked on this profile.

  • What drugs does Clearmind Medicine develop or market?

    We link 1 drug profile(s) where Clearmind Medicine is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/clearmind-medicine#company-drugs.

  • What are the latest developments for Clearmind Medicine?

    In the last 12 months our linked public records show 1 trial program update(s) and 2 US patent grant(s) tied to this profile.

  • What therapeutic areas does Clearmind Medicine focus on?

    Clearmind Medicine focuses on Alcohol Use Disorder based on our analysis of their pipeline programs and drug development activities.

Therapeutic focus

Therapeutic area distribution

Pipeline concentration by therapeutic area from linked clinical programs.

Programs by therapeutic area

Others
2